The Somatic Mutation Working Group

of the

SEQC2 Consortium

The objective of the Somatic Mutation Working Group of the Sequencing Quality Control Phase 2 (SEQC2) Consortium is to establish best practices, reference standards, and benchmark the results of somatic mutation detections under different bioinformatic and laboratory conditions. 

If you have any question or suggestion with regard to this website, email to ltfang@gmail.com. For questions with regard to the Somatic Mutation Working Group, email to Wenming.Xiao@fda.hhs.gov.

Publication

Additionally

Establishing community reference samples, data, and call sets for benchmarking cancer mutation detection using WGS

-- Li Tai Fang

Towards best practice in cancer mutation detection with WGS and WES

-- Wenming Xiao

Robust cancer mutation detection with deep learning models derived from tumor-normal sequencing data

-- Mohammad Sahraeian 

A multicenter study benchmarking single-cell RNA-seq technologies using reference samples

-- Charles Wang

Internal Data Sharing Solutions